Saturday, October 17th, 2026 — Symposium
#day1

07:00 Registration & Arrival Tea / Coffee
 
08:00 WA Welcome Addresses
Chairs: Alain TAÏEB, France / Lin MA (马琳), China
08:00 WA2
Welcome to China

Lin MA (马琳), China

08:04 WA3
Welcome from Chinese Society of Dermatology, Chinese Medical Association

Furen ZHANG (张福仁), China

08:08 WA4
Welcome from Chinese Association of Rehabilitation Medicine, Dermatology branch

Jianzhong ZHANG (张建中), China

08:12 WA5
Welcome from Beijing Children’s Hospital

Xin NI (倪鑫), China

08:16 WA5
Welcome from Chinese Association of Rehabilitation Medicine

Lidian CHEN, China

08:21 WA1
President address

Alain TAÏEB, France

 
08:30 S1 AD Prevention and Pediatric aspects
Chairs: Michele Louise RAMIEN, Canada / Li-Chuen WONG, Australia
08:30 KL1
Can we prevent or modify atopic dermatitis with early life interventions?

Alan IRVINE, Ireland

08:50 IL1
AD in Early Life: Pediatric and Adolescent Perspectives

Yuan LIANG (梁源), China

09:02#2234 OL1.1
Maternal First‑trimester Unsaturated Fatty Acids and 8‑year Childhood Atopic Dermatitis Risk: A Longitudinal Cohort Study

Limin DOU, China

09:10#2148 OL1.2
Persistent tissue remodeling and immune adaptation in long-term natural remission in atopic dermatitis

Sarang CHAFLE, Switzerland

09:18 QA
Q&A
 
09:30 BS1 Booth Presentations in Break Session 145 min. Refreshment Break & Visit Exhibits
➜ Check the Schedule
 
10:15 S2 Head and Neck AD/Skin Barrier
Chairs: Magdalena Monika TRZECIAK, Poland / Furen ZHANG (张福仁), China
10:15 KL2
Atopic Dermatitis of the Face and Neck: From Molecular Signature to Targeted Therapy

Wei LI, China

10:35 IL2
Selective disruption of the BeTaCellulin–EGFR homeostatic axis contributes to epidermal dysfunction in atopic dermatitis

François NIYONSABA, Japan

10:47#2015 OL2.1
A Moisturizing Cream Containing Prinsepia utilis Oil Ameliorates Phenotypes in a Mouse Model of Atopic Dermatitis

Ying TU, China

10:55#2078 OL2.2
An endogenous antimicrobial peptide restores epidermal homeostasis through LRP1-dependent autophagy in atopic dermatitis

Ge PENG, Japan

11:03#2298 OL2.3
Epidermal TET2 Deficiency Aggravates Atopic Dermatitis by Impairing SPINK7-Associated Antiprotease Homeostasis

Miao QIN, China

11:11 QA
Q&A
 
11:25 S3 Psychiatric and other comorbidities
Chairs: Paul BIGLIARDI, United States of America / Yuxiang ZHI (支玉香), China
11:25 KL3
The mind-skin axis in atopic dermatitis

Carsten FLOHR, United Kingdom

11:45 IL3
Beyond the Skin: The Systemic Comorbidity of Allergic Rhinitis and Asthma in Atopic Dermatitis

De-Yun WANG, Singapore

11:57#2134 OL3.1
Anxiety and Depression in Chinese Adults with Atopic Dermatitis: A Cross-Sectional Study of Prevalence and Association with Disease Severity

Xueshan DU, China

12:05#2222 OL3.2
Inflammatory mechanisms mediate the association between frailty and atopic dermatitis in the UK Biobank cohort

Peizhi DENG, China

12:13#2200 OL3.3
Sex-specific Psychological Burden of Atopic Dermatitis Severity in Chinese Children: A Cross-sectional Study on Anxiety and Depression

Xing ZOU, China

12:21 QA
Q&A
 
12:35 Lunch 01h10
 
13:45 W1 Workshops01h50 (open, on registration* or invitation**)
13:45 SW11
YOUNGSTERS MEETING
Early Career Professionals Training and Competition
Conference C

Mutong ZHAO (赵牧童), China

13:45 SW12
ISAD-OPENED Workshop
Patient-Centered Care in AD
The expanding role of digital tools in clinical management
Ballroom D

Jean-François STALDER, France

13:45 SW13
APADtf Workshop on Guidelines
Asian-Pacific AD Task Force
Ballroom A

Sandipan DHAR, India

13:45 SW14
Traditional Chinese Medicine (TCM) in AD
Evidence and Practice
Main Auditorium

Ellis HON, Hong Kong, China

 
15:35 BS2 Booth Presentations in Break Session 255 min. Refreshment Break & Visit Exhibits
➜ Check the Schedule
 
16:30 W2 Workshops01h50 (open, on registration* or invitation**)
16:30 SW21
YOUNGSTERS MEETING
Early Career Professionals Training and Competition
Conference C

Mutong ZHAO (赵牧童), China

16:30 SW22
ISAD-OPENED Workshop
Patient-Centered Care in AD
Integrative Medicine (TCM)
Ballroom D

Jean-François STALDER, France

16:30 SW23
Implementation of the African AD guidelines
Trust / Train / Treat / Target: Bottom-up approach
A culturally aligned pathway for real-world adoption
Ballroom A

Erereoghor OTROFANOWEI, Nigeria

16:30 SW24
Music Therapy in Atopic Dermatitis Workshop
From Beethoven to Jobim
Main Auditorium

Roberto TAKAOKA, Brazil

 
19:00 Welcome Reception 02h00
 

Sunday, October 18th, 2026 — Symposium
#day2

07:30 Registration & Arrival Tea / Coffee
 
08:00 S4 Scratching the Surface: The Itch–Brain Connection
Chairs: Fang WANG (王芳), China / Martin STEINHOFF, Germany
08:00 KL4
Stress and Itch: A Two-Way Street in Atopic Dermatits

Sonja STÄNDER, Germany

08:20 IL4
How does pain inhibit itch?

Zhou-Feng CHEN (陈宙风), China

08:32#2155 OL4.1
Spatial transcriptomic profiling reveals coordinated neuroimmune remodeling between skin and sensory neurons in experimental atopic dermatitis

Alina TYO, South Korea

08:40 OL4.2
Oral presentation selected from the Call for Abstracts
08:48 OL4.3
Oral presentation selected from the Call for Abstracts
08:56 QA
Q&A
 
09:10 BS3 Booth Presentations in Break Session 345 min. Refreshment Break & Visit Exhibits
➜ Check the Schedule
 
09:55 S5 From tradition to molecular targets: TCM in AD treatment
Chairs: Yanping BAI (白彦萍), China / Linfeng LI, China
09:55 KL5
Traditional Chinese Medicine for Atopic Dermatitis: History, Present and Future

Dacan CHEN (陈达灿), China

10:20 IL5
The role of Traditional Chinese Medicine in the modern treatment of Atopic Dermatitis

Trevor ERIKSON, Canada

10:36#2119 OL5.1
Endocannabinoid System Involvement in Atopic Dermatitis: A Study of Cannabinoid Receptor Expression.

Mark G. KIRCHHOF, Canada

10:44#2229 OL5.2
A Classical Herbal Medicine for a Modern Indication: Experimental Evidence and Bioactive Constituent Analysis of Artemisia annua Extract Against Atopic Dermatitis

Dong ZHANG, China

10:52 QA
Q&A
 
11:05 S6 AD treatment: From RCTs to Real Life
Chairs: Roberto TAKAOKA, Brazil / Yunsheng LIANG (梁云生), China
11:05 KL6
Latest advances in the treatment of atopic dermatitis

Andreas WOLLENBERG, Germany

11:25 IL6
An unmet need persists for topical treatment options in atopic dermatitis

Xu YAO (姚煦), China

11:37#2157 OL6.1
Real-world Comparison of Efficacy Between Dupilumab and JAK Inhibitors in Atopic Dermatitis

Ruojun WANG, China

11:45 OL6.2
Oral presentation selected from the Call for Abstracts
11:53 OL6.3
Oral presentation selected from the Call for Abstracts
12:01 QA
Q&A
 
12:15 Lunch 01h30
 
12:15 IW Industry Workshops (globals)03h00 (open, on registration* or invitation**)
12:30 IW11
LEO Pharma, 60 min. Conference C
13:30 IW12
Pfizer, on invitation only, 105 min. Ballroom A
13:45 IW14
Sanofi, 90 min. Ballroom C
13:45 IW15
Lilly (for HCP only), 90 min. Ballroom D
 
15:15 BS4 Booth Presentations in Break Session 445 min. Refreshment Break & Visit Exhibits
➜ Check the Schedule
 
16:00 S7 AI and Precision Dermatology
Chairs: Sébastien BARBAROT, France / Zigang XU (徐子刚), China
16:00 KL7
Precision Dermatology for Atopic Dermatitis: What AI Can Deliver Today — and What It Cannot Yet

Somesh GUPTA, India

16:20 IL7
Beyond Severity: Cellular Endotypes of Atopic Dermatitis

Dong Hun LEE, South Korea

16:32#2267 OL7.1
Integrated Machine Learning of Skin Microbiome and Transcriptome Identifies Atopic Dermatitis in a Latin American Cohort

Min Ha LEE, Chile

16:40#2005 OL7.2
Dissociation between subjective itch perception and objective scratching behaviour in atopic dermatitis

Xin Yi NG, United Kingdom

16:48#2163 OL7.3
Glycoproteomics Analyses of Atopic dermatitis Reveal Immune-Associated Glycopeptides

Rønghui ZHU, China

16:56
Q&A
 
17:10 IW Industry Workshops (locals)01h30 (open, on registration* or invitation**)
17:10 IW21
Bioderma, 45 min. Ballroom B+C
17:10 IW22
Botanee, 30 min. Ballroom D
17:10 IW23
Kenvue, 90 min. Ballroom A
17:10 IW24
Viatris, 45 min. Conference C
17:40 IW25
Avene, 45 min. Ballroom D
17:55 IW26
Jumpcan, 45 min. Ballroom B+C
17:55 IW27
L’Oréal, 45 min. Conference C
18:25 IW28
Cetaphil, 20 min. Ballroom D
 
19:30 Georg RAJKA Award Ceremony 02h00
 

Monday, October 19th, 2026 — Symposium
#day3

07:30 Registration & Arrival Tea / Coffee
 
08:00 S8 Lessons from targeting cytokines in AD
Chairs: Daria S FOMINA, Russia / Zhirong YAO (姚志荣), China
08:00 KL8
Role of IL-31 in Pruritus of Atopic Dermatitis

Kenji KABASHIMA, Japan

08:20 IL8
Targeting Cytokine Signaling in AD: Opportunities and Challenges

Ke SHUAI (帅克), China

08:32#2111 OL8.1
Tissue-Resident Memory T Cells are Associated with Pathology and Itch in a Chronic Atopic Dermatitis Mouse Model

Jiwoo CHOI, South Korea

08:40#2264 OL8.2
Skin-Associated E-Cadherin-Expressing CD4+ Memory T Cells Exacerbate Colitis in Atopic Dermatitis

Yijun YANG, China

08:48 OL8.3
Oral presentation selected from the Call for Abstracts
08:56 QA
Q&A
 
09:10 BS5 Booth Presentations in Break Session 545 min. Refreshment Break & Visit Exhibits
➜ Check the Schedule
 
09:55 S9 Hot Topics in Research: What Changed This Year in AD?
Chairs: Yang WANG (汪旸), China / John C. SU, Australia
09:55 KL9
From OX40 to GLP-1: A Year of Surprises in Atopic Dermatitis

Christian VESTERGAARD, Denmark

10:15 IL9
Evolving Atopic Dermatitis Therapy in Children Under 12 Years of Age

Lawrence EICHENFIELD, United States of America

10:27#2206 OL9.1
APOE drives immunometabolic reprogramming in dermal fibroblasts to aggravate atopic dermatitis

Qiaochu JIANG, China

10:35#2268 OL9.2
Roseburia hominis derived nicotinic acid ameliorates atopic dermatitis -like dermatitis

Mengxin DONG, China

10:43 OL9.3
Oral presentation selected from the Call for Abstracts
10:51 QA
Q&A
 
11:05 S10 AD: unmet needs, emerging concepts and therapies
Chairs: Dirk-Jan HIJNEN, The Netherlands / Erereoghor OTROFANOWEI, Nigeria
11:05 KL10
Addressing the unmet needs in atopic dermatitis- new technologies, targets and translational advances

Eric SIMPSON, United States of America

11:25 IL10
Emerging topical and systemic treatments for atopic dermatitis

Jianzhong ZHANG (张建中), China

11:37#2004 OL10.1
Global Core Set of Items for Standardised Atopic Dermatitis Prevalence Research

Karl Philipp DREWITZ, Germany

11:45#2175 OL10.2
Staphylococcus aureus Exacerbates Atopic Dermatitis via the PPARγ/ELOVL7 Axis in Inflammatory Dendritic Epidermal Cells

Xin SUI, China

11:53#2098 OL10.3
IL-37 promotes epidermal homeostasis through autophagy-dependent mechanisms in atopic dermatitis

Alafate ABUDOUWANLI, Japan

12:01 QA
Q&A
 
12:15 Lunch + Skin Matters reception 01h30
 
14:00 IND What's new from the industry
Chairs: Kyu Han KIM, South Korea / Javier Andres de Jesus ARELLANO LORCA, Chile
14:00 IND1
Atopic Dermatitis in Transition: Emerging Science and Future Directions
Presentation from Pfizer

Nadir MAMMAR, France

14:20 IND2
Presentation from Lilly
14:33 IND3
Emollient design for atopic dermatitis: efficacy and safety for skin barrier repair
Unifarco Biomedical Presentation

Anna BELLONI-FORTINA, Italy

14:43
Q&A
 
14:50 ECP Grand finale of the Youngsters competition
 
15:35 BS6 Booth Presentations in Break Session 645 min. Refreshment Break & Visit Exhibits
➜ Check the Schedule
 
16:20 SED Essential Drugs in AD
Chairs: Alain TAÏEB, France / Zuotao ZHAO (赵作涛), China
16:20 KL11
Expanding access to medicines for atopic dermatitis: WHO EML perspective

Lorenzo MOJA, Switzerland

 
16:45 REP Reports from the Groups / Workshops
Chairs: Peter SCHMID-GRENDELMEIER, Switzerland / Xinghua GAO (高兴华), China
16:45 REP1
Report from the APADtf
16:57 REP2
Report from the African Guidelines group
17:09 REP4
Report from the Social Media group
17:21 REP6
Report from the Opened Task Force
 
17:55 CC Closing Ceremony
17:55
Best poster/presentation awards, local best posters

Lin MA (马琳), China

18:00
Next Rajka Symposium 2027: Augsburg, Germany

Andreas WOLLENBERG, Germany

18:05
Closing remarks

Alain TAÏEB, France

 
20261007221203 C:20261006